Related Experiment Video
Updated: Mar 14, 2026
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Dramatic reduction of mortality in pneumococcal meningitis
Grete Buchholz1, Uwe Koedel1, Hans-Walter Pfister1
1Department of Neurology, Klinikum Grosshadern, Ludwig Maximilians University, Marchioninistr. 15, 81377, Munich, Germany.
Background:
Acute bacterial meningitis is still a life threatening disease.
Methods:
We performed a retrospective observational study on the clinical characteristics of consecutively admitted patients with acute pneumococcal meningitis in a single tertiary care center in central Europe (from 2003 until 2015). Data were compared with a previously published historical group of 87 patients treated for pneumococcal meningitis at the same hospital (from 1984 until 2002).
Results:
Fifty-five consecutive patients with microbiologically proven pneumococcal meningitis were included. Most striking, mortality was down to 5.5 %, which was significantly lower than in the historical group where 24.1 % of the patients did not survive. Intracranial complications during the course of the disease were common and affected half of the patients. Unlike in the historic group, most of the intracranial complications (except ischemic stroke) were no longer associated with a low Glasgow Outcome Score at discharge.
Conclusion:
The drastic reduction of mortality proves there have been important advances in the treatment of pneumococcal meningitis. Nevertheless, the fact that only 44.2 % of survivors had a full recovery indicates that the search for new adjunctive treatment options must be ongoing.
Insights
Advances in treating pneumococcal meningitis have drastically reduced mortality rates. However, many survivors experience long-term complications, highlighting the need for improved adjunctive therapies.
Area of Science:
- Neurology
- Infectious Diseases
- Clinical Medicine
Background:
- Acute bacterial meningitis remains a life-threatening condition.
- Pneumococcal meningitis is a significant cause of mortality and morbidity.
- Effective treatment strategies are crucial for patient outcomes.
Purpose of the Study:
- To evaluate clinical characteristics of pneumococcal meningitis patients.
- To compare outcomes between contemporary and historical patient cohorts.
- To identify areas for therapeutic improvement.
Main Methods:
- Retrospective observational study.
- Analysis of consecutively admitted patients (2003-2015).
- Comparison with a historical cohort (1984-2002).
Main Results:
- Mortality significantly decreased from 24.1% to 5.5%.
- Intracranial complications affected 50% of patients.
- Most complications, except ischemic stroke, did not correlate with poor outcomes.
Conclusions:
- Treatment advances have dramatically reduced pneumococcal meningitis mortality.
- A significant proportion of survivors have incomplete recovery.
- Further research into adjunctive treatments is essential.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia II: Pathophysiology
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions